FDA Inspection
ATSF NE OfficeATSF NE Office – FDA Inspection, Mar 7, 2017
Record Details
This FDA Inspection record concerns ATSF NE Office, with an inspection on March 7, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 55460f60-3b64-4da3-87ab-47c11329a139
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1017531
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.200(d)Inspected routinely
- 21 CFR 1271.210(a)Use prior to verification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ATSF NE Office
3| Date | Classification | Office | Project area |
|---|---|---|---|
| April 21, 2026 | Not classified | Minneapolis District Office | |
| May 4, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 18, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for ATSF NE Office
- FDA Inspection 1318880 - 2026-04-21
- FDA Inspection 1170922 - 2022-05-04
- FDA Inspection 908387 - 2014-12-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.